Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 166
9
Diseases
77
Unique genes
0.199
Avg. similarity score
Constitutional mismatch repair deficiency
Most-connected disease (7 links)
Disease
Searched: ciliary dyskinesia, primary, 47, and lissencephaly
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
ciliary dyskinesia, primary, 47, and lissencephaly
Constitutional mismatch repair deficiency
Muir-torre syndrome
mismatch repair cancer syndrome 1
Rhabdomyosarcoma
Intellectual developmental disorder dysmorphic behavioral
Lynch syndrome
Turcot syndrome
Cystic leukoencephalopathy
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| Constitutional mismatch repair deficiency | 7 | 7 | 13 |
| Muir-torre syndrome | 6 | 6 | 4 |
| mismatch repair cancer syndrome 1 | 5 | 5 | 4 |
| Rhabdomyosarcoma | 4 | 4 | 27 |
| Intellectual developmental disorder dysmorphic behavioral | 3 | 3 | 3 |
| Lynch syndrome | 3 | 3 | 49 |
| Turcot syndrome | 3 | 3 | 3 |
| Cystic leukoencephalopathy | 2 | 2 | 2 |
| ciliary dyskinesia, primary, 47, and lissencephaly | 1 | 1 | 1 |
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| MLH1 | 6 / 9 | Constitutional mismatch repair deficiency, Lynch syndrome, mismatch repair cancer syndrome 1, Muir-torre syndrome and 2 more |
| MSH6 | 6 / 9 | Constitutional mismatch repair deficiency, Intellectual developmental disorder dysmorphic behavioral, Lynch syndrome, mismatch repair cancer syndrome 1 and 2 more |
| PMS2 | 6 / 9 | Constitutional mismatch repair deficiency, Lynch syndrome, mismatch repair cancer syndrome 1, Muir-torre syndrome and 2 more |
| MSH2 | 5 / 9 | Constitutional mismatch repair deficiency, Lynch syndrome, mismatch repair cancer syndrome 1, Muir-torre syndrome and 1 more |
| APC | 3 / 9 | Constitutional mismatch repair deficiency, Lynch syndrome, Turcot syndrome |
| RNASET2 | 3 / 9 | Constitutional mismatch repair deficiency, Cystic leukoencephalopathy, Lynch syndrome |
| ASTE1 | 2 / 9 | Constitutional mismatch repair deficiency, Lynch syndrome |
| FBXO11 | 2 / 9 | Intellectual developmental disorder dysmorphic behavioral, Lynch syndrome |
| SLC22A9 | 2 / 9 | Constitutional mismatch repair deficiency, Lynch syndrome |
| TAF1B | 2 / 9 | Constitutional mismatch repair deficiency, Lynch syndrome |
| TGFBR2 | 2 / 9 | Constitutional mismatch repair deficiency, Lynch syndrome |
| TP73 | 2 / 9 | ciliary dyskinesia, primary, 47, and lissencephaly, Rhabdomyosarcoma |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Colorectal cancer | KEGG | 14 / 87 | 25.1× | 2.14e-16 | 8.93e-14 ✓ sig. |
| Hepatocellular carcinoma | KEGG | 16 / 170 | 14.7× | 8.24e-15 | 2.58e-12 ✓ sig. |
| Cellular senescence | KEGG | 15 / 157 | 14.9× | 4.97e-14 | 1.32e-11 ✓ sig. |
| Pathways in cancer | KEGG | 22 / 533 | 6.4× | 1.17e-12 | 2.50e-10 ✓ sig. |
| Gastric cancer | KEGG | 13 / 150 | 13.5× | 9.85e-12 | 1.80e-9 ✓ sig. |
| AGE-RAGE signaling pathway in diabetic complications | KEGG | 11 / 101 | 17.0× | 3.60e-11 | 5.83e-9 ✓ sig. |
| Pancreatic cancer | KEGG | 10 / 77 | 20.3× | 4.99e-11 | 7.78e-9 ✓ sig. |
| Chronic myeloid leukemia | KEGG | 10 / 77 | 20.3× | 4.99e-11 | 7.78e-9 ✓ sig. |
| Mismatch repair | KEGG | 7 / 23 | 47.5× | 7.61e-11 | 1.14e-8 ✓ sig. |
| Cell cycle | KEGG | 12 / 158 | 11.8× | 3.11e-10 | 4.10e-8 ✓ sig. |
| Platinum drug resistance | KEGG | 9 / 75 | 18.7× | 1.01e-9 | 1.18e-7 ✓ sig. |
| Human T-cell leukemia virus 1 infection | KEGG | 13 / 224 | 9.1× | 1.49e-9 | 1.67e-7 ✓ sig. |
| TGF-beta receptor signaling activates SMADs | Reactome | 5 / 12 | 65.0× | 7.26e-9 | 6.95e-7 ✓ sig. |
| Homologous DNA Pairing and Strand Exchange | Reactome | 6 / 25 | 37.4× | 9.16e-9 | 8.46e-7 ✓ sig. |
| FoxO signaling pathway | KEGG | 10 / 133 | 11.7× | 1.15e-8 | 1.03e-6 ✓ sig. |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| mismatch repair | GO:0006298 | 11 / 30 | 89.0× | 1.42e-19 | 2.06e-16 ✓ sig. |
| DNA damage response | GO:0006974 | 24 / 577 | 10.1× | 4.18e-18 | 4.92e-15 ✓ sig. |
| DNA repair | GO:0006281 | 19 / 420 | 11.0× | 4.94e-15 | 3.46e-12 ✓ sig. |
| positive regulation of transcription by RNA polymerase II | GO:0045944 | 26 / 1,208 | 5.2× | 8.65e-13 | 4.03e-10 ✓ sig. |
| somatic recombination of immunoglobulin gene segments | GO:0016447 | 5 / 6 | 202× | 6.23e-12 | 2.42e-9 ✓ sig. |
| isotype switching | GO:0045190 | 6 / 19 | 76.6× | 1.04e-10 | 3.04e-8 ✓ sig. |
| activin receptor signaling pathway | GO:0032924 | 6 / 22 | 66.2× | 2.84e-10 | 7.36e-8 ✓ sig. |
| in utero embryonic development | GO:0001701 | 12 / 252 | 11.6× | 4.71e-10 | 1.16e-7 ✓ sig. |
| regulation of cell cycle | GO:0051726 | 12 / 262 | 11.1× | 7.35e-10 | 1.71e-7 ✓ sig. |
| somatic hypermutation of immunoglobulin genes | GO:0016446 | 5 / 14 | 86.7× | 2.02e-9 | 4.21e-7 ✓ sig. |
| positive regulation of DNA-templated transcription | GO:0045893 | 17 / 778 | 5.3× | 1.34e-8 | 2.20e-6 ✓ sig. |
| SMAD protein signal transduction | GO:0060395 | 5 / 25 | 48.5× | 5.19e-8 | 7.06e-6 ✓ sig. |
| double-strand break repair | GO:0006302 | 7 / 87 | 19.5× | 6.85e-8 | 8.90e-6 ✓ sig. |
| regulation of gene expression | GO:0010468 | 12 / 402 | 7.2× | 8.69e-8 | 1.09e-5 ✓ sig. |
| intrinsic apoptotic signaling pathway in response to DNA damage | GO:0008630 | 6 / 54 | 27.0× | 8.86e-8 | 1.11e-5 ✓ sig. |